These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

379 related articles for article (PubMed ID: 34224592)

  • 21. Diamonds in the Rough: Harnessing Tumor-Associated Myeloid Cells for Cancer Therapy.
    Clappaert EJ; Murgaski A; Van Damme H; Kiss M; Laoui D
    Front Immunol; 2018; 9():2250. PubMed ID: 30349530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Granulocytic Myeloid-Derived Suppressor Cells as Negative Regulators of Anticancer Immunity.
    Kramer ED; Abrams SI
    Front Immunol; 2020; 11():1963. PubMed ID: 32983128
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Clinical Relevance and Suppressive Capacity of Human Myeloid-Derived Suppressor Cell Subsets.
    Lang S; Bruderek K; Kaspar C; Höing B; Kanaan O; Dominas N; Hussain T; Droege F; Eyth C; Hadaschik B; Brandau S
    Clin Cancer Res; 2018 Oct; 24(19):4834-4844. PubMed ID: 29914893
    [No Abstract]   [Full Text] [Related]  

  • 24. Levels of peripheral blood polymorphonuclear myeloid-derived suppressor cells and selected cytokines are potentially prognostic of disease progression for patients with non-small cell lung cancer.
    Barrera L; Montes-Servín E; Hernandez-Martinez JM; Orozco-Morales M; Montes-Servín E; Michel-Tello D; Morales-Flores RA; Flores-Estrada D; Arrieta O
    Cancer Immunol Immunother; 2018 Sep; 67(9):1393-1406. PubMed ID: 29974189
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Exosomes as mediators of immune regulation and immunotherapy in cancer.
    Kugeratski FG; Kalluri R
    FEBS J; 2021 Jan; 288(1):10-35. PubMed ID: 32910536
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Myeloid Cell Modulation by Tumor-Derived Extracellular Vesicles.
    Arkhypov I; Lasser S; Petrova V; Weber R; Groth C; Utikal J; Altevogt P; Umansky V
    Int J Mol Sci; 2020 Aug; 21(17):. PubMed ID: 32878277
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interaction Between MDSC and NK Cells in Solid and Hematological Malignancies: Impact on HSCT.
    Tumino N; Di Pace AL; Besi F; Quatrini L; Vacca P; Moretta L
    Front Immunol; 2021; 12():638841. PubMed ID: 33679798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Increased circulating polymorphonuclear myeloid-derived suppressor cells are associated with prognosis of metastatic castration-resistant prostate cancer.
    Kobayashi T; Nagata M; Hachiya T; Wakita H; Ikehata Y; Takahashi K; China T; Shimizu F; Lu J; Jin Y; Lu Y; Ide H; Horie S
    Front Immunol; 2024; 15():1372771. PubMed ID: 38887300
    [TBL] [Abstract][Full Text] [Related]  

  • 29. AMPK Alpha-1 Intrinsically Regulates the Function and Differentiation of Tumor Myeloid-Derived Suppressor Cells.
    Trillo-Tinoco J; Sierra RA; Mohamed E; Cao Y; de Mingo-Pulido Á; Gilvary DL; Anadon CM; Costich TL; Wei S; Flores ER; Ruffell B; Conejo-Garcia JR; Rodriguez PC
    Cancer Res; 2019 Oct; 79(19):5034-5047. PubMed ID: 31409640
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Blocking Migration of Polymorphonuclear Myeloid-Derived Suppressor Cells Inhibits Mouse Melanoma Progression.
    Groth C; Arpinati L; Shaul ME; Winkler N; Diester K; Gengenbacher N; Weber R; Arkhypov I; Lasser S; Petrova V; Augustin HG; Altevogt P; Utikal J; Fridlender ZG; Umansky V
    Cancers (Basel); 2021 Feb; 13(4):. PubMed ID: 33578808
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic Approaches Targeting the Natural Killer-Myeloid Cell Axis in the Tumor Microenvironment.
    Carnevalli LS; Ghadially H; Barry ST
    Front Immunol; 2021; 12():633685. PubMed ID: 33953710
    [TBL] [Abstract][Full Text] [Related]  

  • 32. MDSC; the Most Important Cell You Have Never Heard Of.
    Tesi RJ
    Trends Pharmacol Sci; 2019 Jan; 40(1):4-7. PubMed ID: 30527590
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Myeloid-Derived Suppressor Cells: Immune-Suppressive Cells That Impair Antitumor Immunity and Are Sculpted by Their Environment.
    Ostrand-Rosenberg S; Fenselau C
    J Immunol; 2018 Jan; 200(2):422-431. PubMed ID: 29311384
    [TBL] [Abstract][Full Text] [Related]  

  • 34. CD300ld on neutrophils is required for tumour-driven immune suppression.
    Wang C; Zheng X; Zhang J; Jiang X; Wang J; Li Y; Li X; Shen G; Peng J; Zheng P; Gu Y; Chen J; Lin M; Deng C; Gao H; Lu Z; Zhao Y; Luo M
    Nature; 2023 Sep; 621(7980):830-839. PubMed ID: 37674079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neutrophils and PMN-MDSC: Their biological role and interaction with stromal cells.
    Zhou J; Nefedova Y; Lei A; Gabrilovich D
    Semin Immunol; 2018 Feb; 35():19-28. PubMed ID: 29254756
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Importance of myeloid derived suppressor cells in cancer from a biomarker perspective.
    Kalathil SG; Thanavala Y
    Cell Immunol; 2021 Mar; 361():104280. PubMed ID: 33445053
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The Role of Myeloid-Derived Suppressor Cells in Tumor Growth and Metastasis.
    Bayik D; Lee J; Lathia JD
    Exp Suppl; 2022; 113():189-217. PubMed ID: 35165865
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Myeloid Derived Suppressor Cells Interactions With Natural Killer Cells and Pro-angiogenic Activities: Roles in Tumor Progression.
    Bruno A; Mortara L; Baci D; Noonan DM; Albini A
    Front Immunol; 2019; 10():771. PubMed ID: 31057536
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Contribution of the Immune System in Bone Metastasis Pathogenesis.
    Xiang L; Gilkes DM
    Int J Mol Sci; 2019 Feb; 20(4):. PubMed ID: 30823602
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Neutrophil: A New Player in Metastatic Cancers.
    Wu M; Ma M; Tan Z; Zheng H; Liu X
    Front Immunol; 2020; 11():565165. PubMed ID: 33101283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.